SG11202006813TA - Fasoracetam crystalline forms - Google Patents
Fasoracetam crystalline formsInfo
- Publication number
- SG11202006813TA SG11202006813TA SG11202006813TA SG11202006813TA SG11202006813TA SG 11202006813T A SG11202006813T A SG 11202006813TA SG 11202006813T A SG11202006813T A SG 11202006813TA SG 11202006813T A SG11202006813T A SG 11202006813TA SG 11202006813T A SG11202006813T A SG 11202006813TA
- Authority
- SG
- Singapore
- Prior art keywords
- fasoracetam
- crystalline forms
- crystalline
- forms
- fasoracetam crystalline
- Prior art date
Links
- GOWRRBABHQUJMX-MRVPVSSYSA-N Fasoracetam Chemical compound C1CCCCN1C(=O)[C@H]1CCC(=O)N1 GOWRRBABHQUJMX-MRVPVSSYSA-N 0.000 title 1
- 229950010008 fasoracetam Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862619031P | 2018-01-18 | 2018-01-18 | |
US201862668108P | 2018-05-07 | 2018-05-07 | |
US201862683419P | 2018-06-11 | 2018-06-11 | |
PCT/US2019/014027 WO2019143829A1 (en) | 2018-01-18 | 2019-01-17 | Fasoracetam crystalline forms |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202006813TA true SG11202006813TA (en) | 2020-08-28 |
Family
ID=67301590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202006813TA SG11202006813TA (en) | 2018-01-18 | 2019-01-17 | Fasoracetam crystalline forms |
Country Status (12)
Country | Link |
---|---|
US (2) | US11535604B2 (en) |
EP (1) | EP3740587A4 (en) |
JP (1) | JP2021511336A (en) |
KR (1) | KR20200135771A (en) |
CN (1) | CN111936463A (en) |
AU (1) | AU2019209870B2 (en) |
BR (1) | BR112020014675A2 (en) |
CA (1) | CA3088970A1 (en) |
IL (1) | IL276108A (en) |
SG (1) | SG11202006813TA (en) |
WO (1) | WO2019143829A1 (en) |
ZA (1) | ZA202004942B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2597100A1 (en) * | 1986-01-21 | 1987-10-16 | Nippon Shinyaku Co Ltd | PYROGLUTAMIDE DERIVATIVES |
US5652249A (en) * | 1993-07-28 | 1997-07-29 | Nippon Shinyaku Co., Inc. | Method of treating depression |
US11219617B2 (en) * | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
DK3347014T3 (en) | 2015-09-08 | 2021-12-06 | Childrens Hospital Philadelphia | Methods for diagnosing and treating Tourette's syndrome |
EP3509640A1 (en) | 2016-09-07 | 2019-07-17 | The Children's Hospital of Philadelphia | Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder |
EP3740204A4 (en) * | 2018-01-18 | 2021-10-06 | The Children's Hospital Of Philadelphia | SOLID FORMS OF FASORACETAM |
-
2019
- 2019-01-17 SG SG11202006813TA patent/SG11202006813TA/en unknown
- 2019-01-17 WO PCT/US2019/014027 patent/WO2019143829A1/en unknown
- 2019-01-17 AU AU2019209870A patent/AU2019209870B2/en active Active
- 2019-01-17 CA CA3088970A patent/CA3088970A1/en active Pending
- 2019-01-17 US US16/963,494 patent/US11535604B2/en active Active
- 2019-01-17 KR KR1020207023804A patent/KR20200135771A/en not_active Ceased
- 2019-01-17 EP EP19740868.5A patent/EP3740587A4/en active Pending
- 2019-01-17 BR BR112020014675-7A patent/BR112020014675A2/en unknown
- 2019-01-17 CN CN201980020105.4A patent/CN111936463A/en active Pending
- 2019-01-17 JP JP2020540328A patent/JP2021511336A/en active Pending
-
2020
- 2020-07-16 IL IL276108A patent/IL276108A/en unknown
- 2020-08-11 ZA ZA2020/04942A patent/ZA202004942B/en unknown
-
2022
- 2022-11-30 US US18/060,098 patent/US12110284B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111936463A (en) | 2020-11-13 |
BR112020014675A2 (en) | 2021-02-17 |
US11535604B2 (en) | 2022-12-27 |
ZA202004942B (en) | 2023-12-20 |
WO2019143829A1 (en) | 2019-07-25 |
AU2019209870A1 (en) | 2020-09-03 |
US20230088814A1 (en) | 2023-03-23 |
US20210047288A1 (en) | 2021-02-18 |
JP2021511336A (en) | 2021-05-06 |
US12110284B2 (en) | 2024-10-08 |
EP3740587A4 (en) | 2021-10-13 |
CA3088970A1 (en) | 2019-07-25 |
AU2019209870B2 (en) | 2024-06-13 |
EP3740587A1 (en) | 2020-11-25 |
IL276108A (en) | 2020-08-31 |
KR20200135771A (en) | 2020-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273730A (en) | Crystalline forms | |
IL276644A (en) | Novel crystalline forms | |
DK3467457T3 (en) | Vibrationssensor | |
DK3759096T3 (en) | Cd73-inhibitorer | |
PT3810587T (en) | Substituted alkoxypyridinyl indolsulfonamides | |
CA185383S (en) | Casque | |
CA185384S (en) | Casque | |
CA185382S (en) | Casque | |
CA185385S (en) | Casque | |
DK3554057T3 (en) | Audioheadsetsystem | |
DK3768830T3 (en) | Cancerterapi | |
DK3613739T3 (en) | Integrin-antagonister | |
DK3753395T3 (en) | Indvendigt luftstyringssystem | |
CA184990S (en) | Uroflowmeter | |
CA184994S (en) | Uroflowmeter | |
DK3633783T3 (en) | Universal-powerbank | |
IL265445A (en) | Crystalline forms | |
DK3674425T3 (en) | Stålwire | |
DK3650069T3 (en) | Trakeostomiventil | |
DK3578923T3 (en) | Navigationssystem | |
DK3570498T3 (en) | Adaptivt hvac-styresystem | |
GB201818028D0 (en) | Crystalline materials | |
GB201816445D0 (en) | Crystalline materials | |
IL276108A (en) | Fasoracetam crystalline forms | |
GB201911797D0 (en) | Crystalline forms |